Please Wait...

Neurogranin

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Neurogranin is a post-synaptic protein regulating synaptic plasticity, learning and memory consolidation. Neurogranin is thought to be involved in activity-dependent synaptic plasticity and long-term potentiation through the modulation of calcium-mediated signaling pathways. Because of its abundant and preferential neuronal expression, Neurogranin has been identified as a potential marker of neurodegeneration in large-scale gene arrays,  along with other candidate markers such as VILIP-1 (Laterza et al., 2006). Several studies have shown that CSF Neurogranin levels are increased in AD, even at the early clinical stages, and could predict cognitive deterioration (Janelidze et al., 2015; Portelius et al., 2015; Sun et al., 2016; Thorsell et al., 2010).

Bioclinica Lab employs a manual sandwich immunoassay designed for the measurement of Neurogranin in human cerebrospinal fluid.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Join Bioclinica in a live #Xtalks webinar 10/31 exploring challenges & benefits of different sourcing models to man… https://t.co/kRYNc1Z3gj
bioclinica (2 hours ago)
Bioclinica contributions toward advancement of #Alzheimer's disease research & therapies showcased in 8 different s… https://t.co/j96UN9568o
bioclinica (8 hours ago)
Bioclinica’s Joby John reflects on the #SCDM2018 Annual Conference & being a part a thriving community of clinical… https://t.co/c70gH5kJo9
bioclinica (Yesterday)
RT @bioclinica: Our own Jeff Heilbraun is in Tokyo nxt wk to lead a discussion at DIA’s Cardiac Safety Workshop in Japan. Jeff will give an…
bioclinica (Yesterday)
RT @Xtalks: Trends in #SitePayments: Insight into How CROs Can Gain a Competitive Edge This webinar will focus on the latest market researc…
bioclinica (Yesterday)
Great connecting w @bioclinica clients Odonate Therapeutics, Eisai, & PCI Biotech, at #ESMO18 #oncology… https://t.co/4wKrLof8e6
bioclinica (Yesterday)

Latest Blogs:

Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner